491 lines
24 KiB
HTML
491 lines
24 KiB
HTML
|
||
<!DOCTYPE html>
|
||
<html lang="zh-CN">
|
||
<head>
|
||
<meta charset="utf-8" />
|
||
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
|
||
<title>维生素行业洞察报告</title>
|
||
<link href="https://fonts.googleapis.com/css?family=Inter:300,400,500,600,700,800" rel="stylesheet" />
|
||
<link href="https://cdn.jsdelivr.net/npm/tailwindcss@2.2.19/dist/tailwind.min.css" rel="stylesheet">
|
||
<link href="https://cdn.jsdelivr.net/npm/daisyui@5" rel="stylesheet" type="text/css" />
|
||
<link href="https://cdn.jsdelivr.net/npm/daisyui@5/themes.css" rel="stylesheet" type="text/css" />
|
||
<script src="https://kit.fontawesome.com/1d2b6c4f81.js" crossorigin="anonymous"></script>
|
||
<script src="https://cdn.jsdelivr.net/npm/tsparticles@3/tsparticles.bundle.min.js"></script>
|
||
<script src="https://cdnjs.cloudflare.com/ajax/libs/three.js/r134/three.min.js"></script>
|
||
<script src="https://cdnjs.cloudflare.com/ajax/libs/vanta/0.5.24/vanta.waves.min.js"></script>
|
||
<style>
|
||
.timeline-item {
|
||
position: relative;
|
||
padding-left: 30px;
|
||
}
|
||
.timeline-item::before {
|
||
content: '';
|
||
position: absolute;
|
||
left: 0;
|
||
top: 5px;
|
||
width: 12px;
|
||
height: 12px;
|
||
border-radius: 50%;
|
||
background-color: #10b981;
|
||
}
|
||
.timeline-item::after {
|
||
content: '';
|
||
position: absolute;
|
||
left: 5px;
|
||
top: 17px;
|
||
width: 2px;
|
||
height: calc(100% + 10px);
|
||
background-color: #d1d5db;
|
||
}
|
||
.timeline-item:last-child::after {
|
||
display: none;
|
||
}
|
||
.card-hover {
|
||
transition: all 0.3s ease;
|
||
}
|
||
.card-hover:hover {
|
||
transform: translateY(-5px);
|
||
box-shadow: 0 10px 25px rgba(0, 0, 0, 0.1);
|
||
}
|
||
.gradient-text {
|
||
background: linear-gradient(135deg, #10b981 0%, #3b82f6 100%);
|
||
-webkit-background-clip: text;
|
||
-webkit-text-fill-color: transparent;
|
||
background-clip: text;
|
||
}
|
||
.table-cell-wrap {
|
||
white-space: normal;
|
||
word-wrap: break-word;
|
||
}
|
||
#vanta-bg {
|
||
position: fixed;
|
||
top: 0;
|
||
left: 0;
|
||
width: 100%;
|
||
height: 100%;
|
||
z-index: -1;
|
||
}
|
||
.content-wrapper {
|
||
position: relative;
|
||
z-index: 1;
|
||
background-color: rgba(255, 255, 255, 0.95);
|
||
backdrop-filter: blur(10px);
|
||
}
|
||
</style>
|
||
</head>
|
||
<body class="bg-gray-50">
|
||
<div id="vanta-bg"></div>
|
||
|
||
<div class="content-wrapper min-h-screen py-8 px-4 md:px-8">
|
||
<!-- 标题部分 -->
|
||
<div class="max-w-6xl mx-auto mb-10">
|
||
<div class="text-center mb-8">
|
||
<h1 class="text-4xl md:text-5xl font-bold gradient-text mb-4">维生素行业洞察报告</h1>
|
||
<p class="text-lg text-gray-600 max-w-3xl mx-auto">
|
||
深度分析维生素A/E市场供需格局、价格走势及投资机会
|
||
</p>
|
||
</div>
|
||
|
||
<!-- 核心观点摘要 -->
|
||
<div class="bg-gradient-to-r from-green-50 to-blue-50 rounded-xl p-6 mb-10 card-hover">
|
||
<h2 class="text-2xl font-bold text-gray-800 mb-4 flex items-center">
|
||
<i class="fas fa-lightbulb text-yellow-500 mr-3"></i>核心观点摘要
|
||
</h2>
|
||
<div class="grid md:grid-cols-3 gap-4">
|
||
<div class="bg-white rounded-lg p-4 shadow-sm">
|
||
<h3 class="font-semibold text-green-600 mb-2">当前阶段</h3>
|
||
<p class="text-gray-700">维生素A/E处于<strong>供给驱动型超级周期</strong>，价格已脱离成本区间，进入<strong>情绪溢价阶段</strong></p>
|
||
</div>
|
||
<div class="bg-white rounded-lg p-4 shadow-sm">
|
||
<h3 class="font-semibold text-blue-600 mb-2">核心驱动力</h3>
|
||
<p class="text-gray-700">巴斯夫停产（全球VA/E产能占比27%/30%）+国内寡头控货+海外补库（2024年VE出口累计+34.3%）</p>
|
||
</div>
|
||
<div class="bg-white rounded-lg p-4 shadow-sm">
|
||
<h3 class="font-semibold text-purple-600 mb-2">未来潜力</h3>
|
||
<p class="text-gray-700">若巴斯夫2025年复产不及预期，<strong>VE价格可能突破200元/kg</strong>（当前142.5元/kg）</p>
|
||
</div>
|
||
</div>
|
||
</div>
|
||
|
||
<!-- 时间轴部分 -->
|
||
<div class="bg-white rounded-xl p-6 mb-10 card-hover">
|
||
<h2 class="text-2xl font-bold text-gray-800 mb-6 flex items-center">
|
||
<i class="fas fa-history text-blue-500 mr-3"></i>维生素行业关键事件时间轴
|
||
</h2>
|
||
<div class="space-y-4">
|
||
<div class="timeline-item">
|
||
<div class="bg-blue-50 rounded-lg p-4">
|
||
<div class="flex justify-between items-start mb-2">
|
||
<h3 class="font-semibold text-blue-700">2024-07-29</h3>
|
||
<span class="bg-blue-100 text-blue-800 text-xs px-2 py-1 rounded">事件起点</span>
|
||
</div>
|
||
<p class="text-gray-700">巴斯夫德国路德维希港工厂爆炸，导致维生素A/E关键中间体（柠檬醛、间甲酚）供应中断</p>
|
||
</div>
|
||
</div>
|
||
|
||
<div class="timeline-item">
|
||
<div class="bg-yellow-50 rounded-lg p-4">
|
||
<div class="flex justify-between items-start mb-2">
|
||
<h3 class="font-semibold text-yellow-700">2024-08-07</h3>
|
||
<span class="bg-yellow-100 text-yellow-800 text-xs px-2 py-1 rounded">不可抗力</span>
|
||
</div>
|
||
<p class="text-gray-700">巴斯夫宣布不可抗力，暂停维生素A/E发货至2025年4月（VA）和2025年7月（VE）</p>
|
||
</div>
|
||
</div>
|
||
|
||
<div class="timeline-item">
|
||
<div class="bg-orange-50 rounded-lg p-4">
|
||
<div class="flex justify-between items-start mb-2">
|
||
<h3 class="font-semibold text-orange-700">2024-08-11</h3>
|
||
<span class="bg-orange-100 text-orange-800 text-xs px-2 py-1 rounded">价格跳涨</span>
|
||
</div>
|
||
<p class="text-gray-700">光大化工会议确认巴斯夫复产延迟，<strong>VE价格从95元/kg跳涨至235元/kg（+147%）</strong>，VA从100元/kg涨至165元/kg（+65%）</p>
|
||
</div>
|
||
</div>
|
||
|
||
<div class="timeline-item">
|
||
<div class="bg-red-50 rounded-lg p-4">
|
||
<div class="flex justify-between items-start mb-2">
|
||
<h3 class="font-semibold text-red-700">2024-09-18</h3>
|
||
<span class="bg-red-100 text-red-800 text-xs px-2 py-1 rounded">业绩弹性</span>
|
||
</div>
|
||
<p class="text-gray-700">德邦医药指出"维生素A/E库存见底，终端开始接受高价"，<strong>浙江医药被定义为"业绩弹性最大标的"</strong>（VE每涨10元/kg利润增厚3亿）</p>
|
||
</div>
|
||
</div>
|
||
|
||
<div class="timeline-item">
|
||
<div class="bg-green-50 rounded-lg p-4">
|
||
<div class="flex justify-between items-start mb-2">
|
||
<h3 class="font-semibold text-green-700">2024-10-28</h3>
|
||
<span class="bg-green-100 text-green-800 text-xs px-2 py-1 rounded">出口增长</span>
|
||
</div>
|
||
<p class="text-gray-700">华福证券月报显示，<strong>VE出口量9月同比+41.4%</strong>，巴斯夫复产延迟至2025年7月，国内检修季叠加海外补库，价格维持高位</p>
|
||
</div>
|
||
</div>
|
||
</div>
|
||
</div>
|
||
|
||
<!-- 核心逻辑分析 -->
|
||
<div class="grid md:grid-cols-2 gap-6 mb-10">
|
||
<div class="bg-white rounded-xl p-6 card-hover">
|
||
<h2 class="text-2xl font-bold text-gray-800 mb-4 flex items-center">
|
||
<i class="fas fa-chart-line text-green-500 mr-3"></i>核心驱动力
|
||
</h2>
|
||
<div class="space-y-3">
|
||
<div class="flex items-start">
|
||
<div class="bg-green-100 rounded-full p-2 mr-3 mt-1">
|
||
<i class="fas fa-industry text-green-600 text-sm"></i>
|
||
</div>
|
||
<div>
|
||
<h3 class="font-semibold text-gray-800">供给端硬缺口</h3>
|
||
<p class="text-gray-600 text-sm">巴斯夫停产导致全球VA/E有效产能减少<strong>20-25%</strong>，国内检修季进一步收紧供应</p>
|
||
</div>
|
||
</div>
|
||
|
||
<div class="flex items-start">
|
||
<div class="bg-blue-100 rounded-full p-2 mr-3 mt-1">
|
||
<i class="fas fa-shopping-cart text-blue-600 text-sm"></i>
|
||
</div>
|
||
<div>
|
||
<h3 class="font-semibold text-gray-800">需求端刚性</h3>
|
||
<p class="text-gray-600 text-sm">饲料添加剂占维生素需求70%，2024年生猪养殖利润<strong>单头盈利超500元</strong></p>
|
||
</div>
|
||
</div>
|
||
|
||
<div class="flex items-start">
|
||
<div class="bg-purple-100 rounded-full p-2 mr-3 mt-1">
|
||
<i class="fas fa-warehouse text-purple-600 text-sm"></i>
|
||
</div>
|
||
<div>
|
||
<h3 class="font-semibold text-gray-800">库存周期</h3>
|
||
<p class="text-gray-600 text-sm">海外进入补库周期（<strong>VE出口1-9月累计+32.5%</strong>），国内贸易商库存仅1.6个月</p>
|
||
</div>
|
||
</div>
|
||
</div>
|
||
</div>
|
||
|
||
<div class="bg-white rounded-xl p-6 card-hover">
|
||
<h2 class="text-2xl font-bold text-gray-800 mb-4 flex items-center">
|
||
<i class="fas fa-exclamation-triangle text-yellow-500 mr-3"></i>预期差分析
|
||
</h2>
|
||
<div class="space-y-3">
|
||
<div class="bg-yellow-50 rounded-lg p-4">
|
||
<h3 class="font-semibold text-yellow-700 mb-2">被忽略的关键点</h3>
|
||
<ul class="text-gray-700 text-sm space-y-2">
|
||
<li class="flex items-start">
|
||
<i class="fas fa-check-circle text-yellow-500 mr-2 mt-0.5"></i>
|
||
<span><strong>VE技术壁垒更高</strong>：新和成采用"丙酮转位法"无需间甲酚，成本比浙江医药低<strong>30%</strong></span>
|
||
</li>
|
||
<li class="flex items-start">
|
||
<i class="fas fa-check-circle text-yellow-500 mr-2 mt-0.5"></i>
|
||
<span><strong>巴斯夫复产不确定性</strong>：专家路演指出"德国工厂设备老化，复产可能延迟至2025年底"</span>
|
||
</li>
|
||
</ul>
|
||
</div>
|
||
|
||
<div class="bg-red-50 rounded-lg p-4">
|
||
<h3 class="font-semibold text-red-700 mb-2">市场分歧点</h3>
|
||
<p class="text-gray-700 text-sm">市场担忧万华化学4.8万吨柠檬醛投产（2025年）可能压制VA价格，但对VE影响有限（VE无需柠檬醛）</p>
|
||
</div>
|
||
</div>
|
||
</div>
|
||
</div>
|
||
|
||
<!-- 产业链分析 -->
|
||
<div class="bg-white rounded-xl p-6 mb-10 card-hover">
|
||
<h2 class="text-2xl font-bold text-gray-800 mb-6 flex items-center">
|
||
<i class="fas fa-sitemap text-purple-500 mr-3"></i>产业链与核心公司深度剖析
|
||
</h2>
|
||
|
||
<div class="grid md:grid-cols-3 gap-6 mb-6">
|
||
<div class="bg-gradient-to-b from-purple-50 to-purple-100 rounded-lg p-4">
|
||
<h3 class="font-semibold text-purple-700 mb-3 flex items-center">
|
||
<i class="fas fa-arrow-up mr-2"></i>上游
|
||
</h3>
|
||
<ul class="text-gray-700 text-sm space-y-2">
|
||
<li>• 柠檬醛（巴斯夫垄断）</li>
|
||
<li>• 间甲酚（辉隆股份供应浙江医药）</li>
|
||
<li>• NF胆固醇（花园生物垄断VD3原料）</li>
|
||
</ul>
|
||
</div>
|
||
|
||
<div class="bg-gradient-to-b from-blue-50 to-blue-100 rounded-lg p-4">
|
||
<h3 class="font-semibold text-blue-700 mb-3 flex items-center">
|
||
<i class="fas fa-exchange-alt mr-2"></i>中游
|
||
</h3>
|
||
<ul class="text-gray-700 text-sm space-y-2">
|
||
<li>• VA/E生产（新和成、浙江医药、巴斯夫）</li>
|
||
<li>• VD3（花园生物）</li>
|
||
</ul>
|
||
</div>
|
||
|
||
<div class="bg-gradient-to-b from-green-50 to-green-100 rounded-lg p-4">
|
||
<h3 class="font-semibold text-green-700 mb-3 flex items-center">
|
||
<i class="fas fa-arrow-down mr-2"></i>下游
|
||
</h3>
|
||
<ul class="text-gray-700 text-sm space-y-2">
|
||
<li>• 饲料（新希望、牧原）</li>
|
||
<li>• 食品（保健品）</li>
|
||
<li>• 医药</li>
|
||
</ul>
|
||
</div>
|
||
</div>
|
||
|
||
<div class="bg-gray-50 rounded-lg p-4">
|
||
<h3 class="font-semibold text-gray-800 mb-3">核心玩家对比</h3>
|
||
<div class="overflow-x-auto">
|
||
<table class="w-full text-sm">
|
||
<thead>
|
||
<tr class="bg-gray-200">
|
||
<th class="text-left p-3 font-semibold">公司</th>
|
||
<th class="text-left p-3 font-semibold">核心产品</th>
|
||
<th class="text-left p-3 font-semibold">竞争优势</th>
|
||
<th class="text-left p-3 font-semibold">潜在风险</th>
|
||
</tr>
|
||
</thead>
|
||
<tbody>
|
||
<tr class="border-b">
|
||
<td class="p-3 font-medium">新和成</td>
|
||
<td class="p-3">VE/VA</td>
|
||
<td class="p-3">全产业链+成本最低（VE成本35元/kg）</td>
|
||
<td class="p-3">检修期产能损失（2025年1月）</td>
|
||
</tr>
|
||
<tr class="border-b">
|
||
<td class="p-3 font-medium">浙江医药</td>
|
||
<td class="p-3">VE/VA</td>
|
||
<td class="p-3">出口占比高（2024年VE出口+41%）</td>
|
||
<td class="p-3">间甲酚涨价挤压利润</td>
|
||
</tr>
|
||
<tr>
|
||
<td class="p-3 font-medium">花园生物</td>
|
||
<td class="p-3">VD3</td>
|
||
<td class="p-3">垄断NF胆固醇（全球70%份额）</td>
|
||
<td class="p-3">VD3替代品（25-羟基D3）渗透</td>
|
||
</tr>
|
||
</tbody>
|
||
</table>
|
||
</div>
|
||
</div>
|
||
</div>
|
||
|
||
<!-- 股票数据表格 -->
|
||
<div class="bg-white rounded-xl p-6 mb-10 card-hover">
|
||
<h2 class="text-2xl font-bold text-gray-800 mb-6 flex items-center">
|
||
<i class="fas fa-table text-indigo-500 mr-3"></i>维生素行业关联股票
|
||
</h2>
|
||
<div class="overflow-x-auto">
|
||
<table class="w-full text-sm">
|
||
<thead>
|
||
<tr class="bg-gradient-to-r from-indigo-500 to-purple-600 text-white">
|
||
<th class="text-left p-3 font-semibold">股票名称</th>
|
||
<th class="text-left p-3 font-semibold">主要产品</th>
|
||
<th class="text-left p-3 font-semibold">行业</th>
|
||
<th class="text-left p-3 font-semibold">投资理由</th>
|
||
</tr>
|
||
</thead>
|
||
<tbody>
|
||
<tr class="border-b hover:bg-gray-50">
|
||
<td class="p-3 font-medium">新和成</td>
|
||
<td class="p-3 table-cell-wrap">VA（50万IU/g）、VE油、VD3（50万IU/g）、VB6、VB7（2%生物素）、VB12（1%含量）</td>
|
||
<td class="p-3">维生素行业</td>
|
||
<td class="p-3 table-cell-wrap">维生素种类丰富，涵盖VA、VE、VD3、VB系列等多类产品，产能规模领先行业</td>
|
||
</tr>
|
||
<tr class="border-b hover:bg-gray-50">
|
||
<td class="p-3 font-medium">浙江医药</td>
|
||
<td class="p-3 table-cell-wrap">VA（50万IU/g）、VE油、VB7（2%生物素）</td>
|
||
<td class="p-3">维生素行业</td>
|
||
<td class="p-3 table-cell-wrap">生产VA、VE及生物素（VB7），具备一定产能规模</td>
|
||
</tr>
|
||
<tr class="border-b hover:bg-gray-50">
|
||
<td class="p-3 font-medium">能特科技</td>
|
||
<td class="p-3 table-cell-wrap">VE油、VB7（2%生物素）</td>
|
||
<td class="p-3">维生素行业</td>
|
||
<td class="p-3 table-cell-wrap">专注于VE及生物素（VB7）生产</td>
|
||
</tr>
|
||
<tr class="border-b hover:bg-gray-50">
|
||
<td class="p-3 font-medium">安迪苏</td>
|
||
<td class="p-3 table-cell-wrap">VA（50万IU/g）</td>
|
||
<td class="p-3">维生素行业</td>
|
||
<td class="p-3 table-cell-wrap">VA产品产能显著</td>
|
||
</tr>
|
||
<tr class="border-b hover:bg-gray-50">
|
||
<td class="p-3 font-medium">花园生物</td>
|
||
<td class="p-3 table-cell-wrap">VD3（50万IU/g）、VA（50万IU/g）</td>
|
||
<td class="p-3">维生素行业</td>
|
||
<td class="p-3 table-cell-wrap">VD3及VA双品类布局</td>
|
||
</tr>
|
||
<tr class="border-b hover:bg-gray-50">
|
||
<td class="p-3 font-medium">金达威</td>
|
||
<td class="p-3 table-cell-wrap">VD3（50万IU/g）、VK2</td>
|
||
<td class="p-3">维生素行业</td>
|
||
<td class="p-3 table-cell-wrap">VD3及维生素K2生产</td>
|
||
</tr>
|
||
<tr class="border-b hover:bg-gray-50">
|
||
<td class="p-3 font-medium">兄弟科技</td>
|
||
<td class="p-3 table-cell-wrap">VB1、VB5（泛酸钙）、VK3</td>
|
||
<td class="p-3">维生素行业</td>
|
||
<td class="p-3 table-cell-wrap">覆盖硫胺素（VB1）、泛酸钙（VB5）及维生素K3</td>
|
||
</tr>
|
||
<tr class="border-b hover:bg-gray-50">
|
||
<td class="p-3 font-medium">振华股份</td>
|
||
<td class="p-3 table-cell-wrap">VK3</td>
|
||
<td class="p-3">维生素行业</td>
|
||
<td class="p-3 table-cell-wrap">专注维生素K3生产</td>
|
||
</tr>
|
||
<tr class="border-b hover:bg-gray-50">
|
||
<td class="p-3 font-medium">梅花生物</td>
|
||
<td class="p-3 table-cell-wrap">VB2</td>
|
||
<td class="p-3">维生素行业</td>
|
||
<td class="p-3 table-cell-wrap">VB2（核黄素）专业生产商</td>
|
||
</tr>
|
||
<tr class="border-b hover:bg-gray-50">
|
||
<td class="p-3 font-medium">广济药业</td>
|
||
<td class="p-3 table-cell-wrap">VB2、VB6</td>
|
||
<td class="p-3">维生素行业</td>
|
||
<td class="p-3 table-cell-wrap">VB2及VB6双品类布局</td>
|
||
</tr>
|
||
<tr class="border-b hover:bg-gray-50">
|
||
<td class="p-3 font-medium">天新药业</td>
|
||
<td class="p-3 table-cell-wrap">VB1、VB6、VB7（2%生物素）</td>
|
||
<td class="p-3">维生素行业</td>
|
||
<td class="p-3 table-cell-wrap">覆盖硫胺素（VB1）、吡哆醇（VB6）及生物素（VB7）</td>
|
||
</tr>
|
||
<tr class="border-b hover:bg-gray-50">
|
||
<td class="p-3 font-medium">巴斯夫</td>
|
||
<td class="p-3 table-cell-wrap">VA（50万IU/g）、VE油</td>
|
||
<td class="p-3">维生素行业</td>
|
||
<td class="p-3 table-cell-wrap">VA及VE主要生产商</td>
|
||
</tr>
|
||
<tr class="hover:bg-gray-50">
|
||
<td class="p-3 font-medium">帝斯曼</td>
|
||
<td class="p-3 table-cell-wrap">VA（50万IU/g）、VE油</td>
|
||
<td class="p-3">维生素行业</td>
|
||
<td class="p-3 table-cell-wrap">VA及VE领域重要参与者</td>
|
||
</tr>
|
||
</tbody>
|
||
</table>
|
||
</div>
|
||
</div>
|
||
|
||
<!-- 风险与结论 -->
|
||
<div class="grid md:grid-cols-2 gap-6 mb-10">
|
||
<div class="bg-white rounded-xl p-6 card-hover">
|
||
<h2 class="text-2xl font-bold text-gray-800 mb-4 flex items-center">
|
||
<i class="fas fa-exclamation-circle text-red-500 mr-3"></i>潜在风险与挑战
|
||
</h2>
|
||
<div class="space-y-3">
|
||
<div class="bg-red-50 rounded-lg p-4">
|
||
<h3 class="font-semibold text-red-700 mb-2">技术风险</h3>
|
||
<p class="text-gray-700 text-sm">25-羟基维生素D3（活性更高）可能替代传统VD3，花园生物已布局1200吨产能，但渗透率仅10%</p>
|
||
</div>
|
||
|
||
<div class="bg-orange-50 rounded-lg p-4">
|
||
<h3 class="font-semibold text-orange-700 mb-2">商业化风险</h3>
|
||
<p class="text-gray-700 text-sm">若2025年生猪养殖利润回落（当前115元/头，环比-41%），饲料需求可能下滑</p>
|
||
</div>
|
||
|
||
<div class="bg-yellow-50 rounded-lg p-4">
|
||
<h3 class="font-semibold text-yellow-700 mb-2">政策风险</h3>
|
||
<p class="text-gray-700 text-sm">欧盟若对中国维生素启动反倾销调查（历史案例：2017年VB2反倾销税），出口或受阻</p>
|
||
</div>
|
||
|
||
<div class="bg-purple-50 rounded-lg p-4">
|
||
<h3 class="font-semibold text-purple-700 mb-2">信息矛盾</h3>
|
||
<p class="text-gray-700 text-sm">巴斯夫复产时间存在<strong>3-6个月预期差</strong>（官方7月 vs 专家年底），需密切跟踪</p>
|
||
</div>
|
||
</div>
|
||
</div>
|
||
|
||
<div class="bg-white rounded-xl p-6 card-hover">
|
||
<h2 class="text-2xl font-bold text-gray-800 mb-4 flex items-center">
|
||
<i class="fas fa-trophy text-yellow-500 mr-3"></i>综合结论与投资启示
|
||
</h2>
|
||
<div class="space-y-4">
|
||
<div class="bg-gradient-to-r from-green-50 to-green-100 rounded-lg p-4">
|
||
<h3 class="font-semibold text-green-700 mb-2">阶段判断</h3>
|
||
<p class="text-gray-700">维生素A/E处于<strong>"供给硬缺口+情绪溢价"</strong>阶段，<strong>VE优于VA</strong>（万华化学对VA冲击更大）</p>
|
||
</div>
|
||
|
||
<div class="bg-gradient-to-r from-blue-50 to-blue-100 rounded-lg p-4">
|
||
<h3 class="font-semibold text-blue-700 mb-2">投资方向</h3>
|
||
<div class="space-y-2 text-gray-700">
|
||
<p><strong>短期（3个月）</strong>：<strong>新和成（VE弹性最大）</strong>+<strong>浙江医药（出口受益）</strong></p>
|
||
<p><strong>长期（1年）</strong>：关注<strong>花园生物（VD3原料垄断）</strong>，若25-羟基D3替代不及预期，可能复制VE行情</p>
|
||
</div>
|
||
</div>
|
||
|
||
<div class="bg-gradient-to-r from-purple-50 to-purple-100 rounded-lg p-4">
|
||
<h3 class="font-semibold text-purple-700 mb-2">跟踪指标</h3>
|
||
<ol class="text-gray-700 text-sm space-y-1">
|
||
<li>1. <strong>巴斯夫复产公告</strong>（2025年Q1关键节点）</li>
|
||
<li>2. <strong>国内检修进度</strong>（新和成/浙江医药2025年1月检修时长）</li>
|
||
<li>3. <strong>生猪养殖利润</strong>（跌破50元/头可能触发需求负反馈）</li>
|
||
</ol>
|
||
</div>
|
||
</div>
|
||
</div>
|
||
</div>
|
||
</div>
|
||
</div>
|
||
|
||
<script>
|
||
// 初始化Vanta.js波浪背景
|
||
VANTA.WAVES({
|
||
el: "#vanta-bg",
|
||
mouseControls: true,
|
||
touchControls: true,
|
||
gyroControls: false,
|
||
minHeight: 200.00,
|
||
minWidth: 200.00,
|
||
scale: 1.00,
|
||
scaleMobile: 1.00,
|
||
color: 0x1a365d,
|
||
shininess: 30.00,
|
||
waveHeight: 10.00,
|
||
waveSpeed: 0.75,
|
||
zoom: 0.65
|
||
});
|
||
</script>
|
||
</body>
|
||
</html>
|
||
``` |